Apr 9 |
ImmuCell reports preliminary Q1 sales, stock climbs 7%
|
Apr 9 |
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
|
Apr 2 |
ImmuCell files for $20M mixed shelf offering
|
Feb 29 |
ImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call Transcript
|
Feb 28 |
ImmuCell Corporation (ICCC) Q4 2023 Earnings Call Transcript
|
Feb 27 |
ImmuCell GAAP EPS of -$0.15, revenue of $5.09M
|
Feb 27 |
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
|
Feb 16 |
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
|
Jan 8 |
ImmuCell says total sale for year ended December falls 6% Y/Y
|
Jan 8 |
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023
|